skip to content

Clinical Neurosciences

Welcome to the Department of Clinical Neurosciences. 

Our mission is to improve the lives of people with neurological illness and injury through discovery, innovative treatments and training the next generation.

We are embedded within Cambridge University Hospitals, allowing our research questions to stem from problems we have encountered in the clinic, and to directly address the needs of patients and families. We work in partnership with the Departments of Psychiatry, Genetics and Paediatrics, to improve brain and mind health, through life, together.

We investigate the mechanisms of brain disease and injury, to devise new diagnostics and treatments, as well as using large data to improve the way we deliver current treatments. Our work has already led to new treatments in use world-wide.

Professor Alasdair Coles
Head of Department

 


 



Support Clinical Neurosciences

Help make an impact through research that enables real clinical progress.

Give online to Clinical Neurosciences at Support Cambridge.

Latest news

Deaf opera singer welcomes new cochlear implant trial

6 May 2026

An upcoming Cambridge-led trial in hearing loss has been called ‘life changing’ by Janine Roebuck, a deaf opera singer who regained her hearing thanks to cochlear implants. The UK trial will provide bilateral (both sides) cochlear implants to some profoundly deaf adults. The results will be used to review NHS guidance for...

Innovative research to develop small molecule drugs for Huntington’s

22 April 2026

In a major new project, Prof Gabriel Balmus (UK DRI at Cambridge) and Prof Sarah Tabrizi (UK DRI at UCL) aim to selectively target DNA repair pathways, to develop disease modifying therapies for Huntington’s. Huntington’s disease is a fatal neurodegenerative condition caused by repetitive expansion of three DNA blocks (C...

First Parkinson’s patient treated in landmark phase 2 trial of Dapansutrile

26 March 2026

The first participant on the Cure Parkinson’s and Van Andel Institute co-funded trial of dapansutrile, an anti-inflammatory drug, has now received either the treatment or placebo, marking the beginning of the trial. Dapansutrile for Parkinson’s (DAPA-PD) is a clinical trial being led by Dr Caroline Williams-Gray at the...

Research Impact Report 2025


Download our PDF report showcasing our latest research findings, major discoveries and trials in 2025:
Clinical Neuroscience Research Impacts Report 2025 
(offsite link)